Diabetes and Endocrinology
GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
Semaglutide linked to declines in intrahepatic triglycerides for people with HIV with metabolic-associated steatotic liver disease
Risks for MACE, Mortality Lower After Surgery for Hyperthyroidism
Compared with patients receiving antithyroid drugs, those receiving surgery have lower risks for MACE, mortality, heart failure
Prevalence of Increased Residual Gastric Content Increased With GLP-1 RAs
GLP-1 RA use associated with higher prevalence of residual gastric content in participants undergoing elective procedure under anesthesia
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
Agency's action could widen access to the drug if more insurance companies decide to cover it
A Number of Teens Meet Criteria for Metabolic, Bariatric Surgery
Male teens, Black and Hispanic teens, and those in more deprived neighborhoods more likely to meet MBS eligibility criteria
Senate Passes Bill to Compensate More Americans Exposed to Radiation
Short Sleep Duration Linked to Increased Risk for Developing T2D
Association between habitual short sleep duration and increased risk for T2D persisted for individuals following healthy diet
Ultraprocessed Foods Increase Risk for Broad Range of Poor Health Outcomes
Findings seen across cardiometabolic, common mental disorder, and mortality outcomes
Higher Use of Health Care Portal Seen During COVID-19 Pandemic
Lower portal activity linked to older age, female sex and for Hispanic/Latinx, non-Hispanic Black, and other race patients
First OTC Continuous Blood Glucose Monitor Cleared for Marketing by FDA
Dexcom Stelo Glucose Biosensor System is intended for people aged 18 years and older who have T2D but do not take insulin
